The reduced rate will still be almost 10 times the average monthly out-of-pocket costs paid by commercially insured patients.

In a bid to alleviate drug pricing pressures, Bristol Myers and Pfizer have announced discounted direct sales of Eliquis for ...

AbbVie is currently running a Phase 2 study on treatments for active psoriatic arthritis. The study explores the efficacy of ...